Supreme Court Rejects Most Pharma Cases This Term, But Patent Settlements Stir Interest
This article was originally published in The Pink Sheet Daily
Executive Summary
High court seeks Solicitor General's view on whether patent settlements blocking authorized generics are anticompetitive; court denies GSK petition challenging payer claims in Avandia litigation.
You may also be interested in...
FTC Review Of Colgate Optic White Claims Stalls Class Action Complaint
A Colgate Optic White whitening claims class action complaint is stayed pending an FTC decision on the claims, says a federal judge in response to Colgate’s motion to dismiss or stay the litigation. The judge denied the firm’s motion to dismiss on the grounds the state suit is pre-empted by FDA regulations.
FTC Review Of Colgate Optic White Claims Delays Class Action Complaint
A Colgate Optic White whitening claims class action complaint is stayed pending an FTC decision on the claims, a federal judge rules. The judge denied the Colgate's motion to dismiss on the grounds the state suit is pre-empted by FDA regulations.
FTC Review Of Colgate Optic White Claims Delays Class Action Complaint
A Colgate Optic White whitening claims class action complaint is stayed pending an FTC decision on the claims, a federal judge rules. The judge denied the Colgate's motion to dismiss on the grounds the state suit is pre-empted by FDA regulations.